About CardioDx
CardioDx was a Consumer company based in Palo Alto (United States) founded in 2004 by David Levison. Online platform offering togel betting and slot games for users. It operates on a B2C and D2C model. CardioDx has raised $281.74 million across 10 funding rounds from investors including SVB, J P Morgan and Kleiner Perkins. The company has 99 employees. Its chief executive, as recorded, is David Levison. The company is recorded as dissolved. CardioDx offers products and services including Togel Platform and Slot Games. Its focus areas include iGaming, Online Gambling, Togel and Slots. Its legal entity is CARDIODX, INC. Its competitors include Invitae, Myriad Genetics and Genome Medical; 2 of its 3 listed competitors have raised funding.
Company details
TOTO88 is an online gambling platform based in Indonesia that offers a range of togel and slot games. Users can place bets on lottery numbers and play slots with features like predictions and statistics to improve winning chances. It operates through a secure website, providing various games and responsive customer support for online gamblers seeking entertainment and potential rewards.
- Headquarters Palo Alto, United States
- Employees 99
- Founders David Levison
- SectorsConsumer
- Website cardiodx.com
- Social X
- Legal Name Cardiodx, Inc.
- Total Equity Funding$281.74M (USD)
in 10 rounds
- Latest Funding Round$18.13M (USD), Series D
Jan 2017
- InvestorsSVB
& 19 more
- Employee Count99
Products & Services of CardioDx
CardioDx offers a comprehensive portfolio of products and services, including Togel Platform and Slot Games.
Platform for betting on lottery numbers with predictions.
Collection of slot games with bonuses and graphics for play.
Funding Insights of CardioDx
CardioDx has successfully raised a total of $281.74M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $18.13 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $281.74M
- Total Rounds 10
- Last Round Series D — $18.13M
- First Round $4.45M
(Jun 2004)
- Investors Count 19
All 10 funding rounds of CardioDx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $18.13M | Series D | – | – | – |
| Feb 2016 | $12.37M | Series D | – | – | – |
| Sep 2015 | $20M | Series D | – | – | |
| Jul 2014 | $35M | Series D | – | AIMCo | |
| May 2014 | $205,804 | Grant | – | – | |
| Aug 2012 | $58M | Series D | – | – | |
| May 2011 | $60M | Series D | – | Longitude Capital, Bright Capital | |
| May 2010 | $34.5M | Series D | – | – | |
| Oct 2008 | $20M | Series C | – | – | – |
| Jul 2006 | $19.3M | Series B | – | – |
20 investors in total: 20 institutional.
Investors in CardioDx
CardioDx has secured backing from 20 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, J P Morgan and Kleiner Perkins.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Debt and equity investments are offered by the firm. | 2006 | solarcapltd.com | New York, United States | |
Venture capital investments are managed in technology and healthcare sectors by this firm. | mdv.com | |||
Investment in technology startups focusing on compute, AI, and related innovations. | intelcapital.com | |||
Mid-stage venture capital investments and support for tech entrepreneurs. | dagventures.com | |||
Early-stage US companies are invested in by Asset Management Ventures. | assetman.com | Palo Alto, United States | ||
Private equity firm focused on life science sector | longitudecapital.com | Menlo Park, United States | ||
Venture capital firm investing in technology and healthcare sectors. | 2000 | artiman.com | ||
Bright Capital is engaged in venture capital and growth equity investments. | 2010 | bright-capital.com | Moscow, Russia | |
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States |
Investor details for CardioDx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CardioDx
1 people are tracked at CardioDx (1 in leadership); the tracked headcount is 99.
| Name | Role | Group |
|---|---|---|
David Levison | Founder, President, CEO | Leadership |
Complete people profiles for CardioDx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CardioDx
3 dated milestones of CardioDx across 13 years, from founding to its latest funding, stage changes and deals.
- Founded CardioDx is founded.
- Funding First funding round of $4.4M.
- Funding Latest funding round, Series D, of $18.1M.
Competitors of CardioDx
CardioDx has 3 listed competitors in our database, 2 of them funded. They include Invitae, Myriad Genetics and Genome Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| myriad.com | 1991 | United States | 2,700 | Molecular diagnostics and personalized medicine for cancer are developed. | ||
| genomemedical.com | 2016 | Monterey, United States | $172.98M | 84 | Genomic testing services are provided clinically and directly to consumers. |
Detailed competitors of CardioDx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CardioDx
Websites that share an audience with CardioDx (cardiodx.com).
Websites whose visitors overlap most with CardioDx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hansenmedical.com | 100% | View details | |||
| pattersoncompanies.com | 93% | 41.9K | #813,341 | View details | |
| masimo.com | 82% | 170.1K | #251,325 | View details | |
| medco.com | 82% | View details | |||
| veracyte.com | 73% | 53.7K | #739,418 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for CardioDx
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Gambling & Entertainment Platforms
3 companies that operate in the same segment as CardioDx (Gambling & Entertainment Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Licensed sports merchandise, collectibles, and betting platforms are provided. | 2011 | New York, New York, United States | USD 4.85 B | 14,656 | ||
Developer of a micro-betting platform for sports | 2022 | Miami, Florida, United States | USD 102 M | |||
Provider of a P2P sports betting platform | 2021 | New York, New York, United States | USD 75 M | 94 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cardiodx
Complete news archive for CardioDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardioDx
CardioDx was founded in 2004.
CardioDx is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
David Levison is the CEO of CardioDx, as recorded in our data. They have also founded this company.
CardioDx is a funded company, having raised a total of $281.74M across 10 funding rounds to date. The company's 1st funding round was a Series B of $19.3M, raised on Jun 2004.
CardioDx has 99 employees.
TOTO88 is an online gambling platform based in Indonesia that offers a range of togel and slot games. Users can place bets on lottery numbers and play slots with features like predictions and statistics to improve winning chances. It operates through a secure website, providing various games and responsive customer support for online gamblers seeking entertainment and potential rewards.
CardioDx's top competitors include Myriad Genetics, Genome Medical and Invitae.
CardioDx offers Togel Platform and Slot Games.
CardioDx has 20 investors. Key investors include SVB, J P Morgan, Kleiner Perkins, TPG, and General Electric.
CardioDx operates through Cardiodx, Inc..